FOXO TECHNOLOGIES INC. Operating Lease, Expense
FOXO TECHNOLOGIES INC. (FOXO) reported Operating Lease, Expense of $211.02 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. operating lease, expense for the quarter ending 2025-09-30 was $211.02K, a 87.31% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating lease, expense for the quarter ending 2025-06-30 was $216.03K, a 1321.45% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating lease, expense for the quarter ending 2025-03-31 was $220.49K.
- FOXO TECHNOLOGIES INC. operating lease, expense for the quarter ending 2024-12-31 was $224.70K.
- FOXO TECHNOLOGIES INC. operating lease, expense for fiscal 2024 was $352.56K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | $211.02K 10-Q · filed 2025-11-10 | $427.05K derived: sum of 2 quarters · filed 2025-11-10 | $647.54K 10-Q · filed 2025-11-10 | $872.24K derived: sum of 4 quarters · filed 2026-04-15 | |||
| 2025-06-30 | $216.03K 10-Q · filed 2025-08-19 | $436.52K 10-Q · filed 2025-08-19 | $661.22K derived: sum of 3 quarters · filed 2026-04-15 | $773.88K derived: sum of 4 quarters · filed 2026-04-15 | |||
| 2025-03-31 | $220.49K 10-Q/A · filed 2025-08-19 | $445.19K derived: sum of 2 quarters · filed 2026-04-15 | $557.85K derived: sum of 3 quarters · filed 2026-04-15 | $573.05K derived: sum of 4 quarters · filed 2026-04-15 | |||
| 2024-12-31 | $224.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $337.36K derived: sum of 2 quarters · filed 2026-04-15 | $352.56K derived: sum of 3 quarters · filed 2026-04-15 | $352.56K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $112.66K 10-Q · filed 2025-11-10 | $113.00K 10-Q · filed 2024-11-19 | $127.86K derived: sum of 2 quarters · filed 2025-11-10 | $127.86K 10-Q · filed 2025-11-10 | $128.00K 10-Q · filed 2024-11-19 | ||
| 2024-06-30 | $15.20K 10-Q · filed 2025-08-19 | $15.00K 10-Q · filed 2024-08-19 | $15.20K 10-Q · filed 2025-08-19 | $15.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |